Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Analysts are anticipating strong performance driven by the https://zakariaubku511546.losblogos.com/35909429/eli-lilly-stock-a-deep-dive-into-q3-earnings